Real-word incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors

Curr Med Res Opin. 2020 Jan;36(1):7-8. doi: 10.1080/03007995.2019.1673581. Epub 2019 Oct 20.

Authors

Daniela Pugliese¹, Luisa Guidi¹, Giuseppe Privitera¹, Alessandro Armuzzi¹

Affiliation

¹ IBD Unit Presidio Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica Del Sacro Cuore, Roma, Italy.

PMID: 31556761
DOI: 10.1080/03007995.2019.1673581

No abstract available

Publication types

Editorial
Comment

MeSH terms

Chronic Disease
Humans
Incidence
Inflammatory Bowel Diseases*
Interleukin-17
Phosphodiesterase 4 Inhibitors*

Substances

Interleukin-17
Phosphodiesterase 4 Inhibitors